AIM IMMUNOTECH INC's ticker is AIM and the CUSIP is 00901B105. A total of 29 filers reported holding AIM IMMUNOTECH INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $38,933 | -32.8% | 85,566 | -1.1% | 0.00% | – |
| Q2 2023 | $57,966 | +55.8% | 86,517 | 0.0% | 0.00% | – |
| Q1 2023 | $37,202 | +37.9% | 86,517 | 0.0% | 0.00% | – |
| Q4 2022 | $26,985 | -46.0% | 86,517 | 0.0% | 0.00% | – |
| Q3 2022 | $50,000 | -27.5% | 86,517 | -2.5% | 0.00% | – |
| Q2 2022 | $69,000 | -26.6% | 88,707 | 0.0% | 0.00% | – |
| Q1 2022 | $94,000 | +14.6% | 88,707 | +0.1% | 0.00% | – |
| Q4 2021 | $82,000 | -54.2% | 88,662 | +0.3% | 0.00% | – |
| Q3 2021 | $179,000 | -4.8% | 88,416 | +1.4% | 0.00% | – |
| Q2 2021 | $188,000 | +22.1% | 87,226 | +28.8% | 0.00% | – |
| Q1 2021 | $154,000 | +33.9% | 67,746 | +5.4% | 0.00% | – |
| Q4 2020 | $115,000 | -17.9% | 64,303 | -1.5% | 0.00% | – |
| Q3 2020 | $140,000 | -2.1% | 65,267 | +13.4% | 0.00% | – |
| Q2 2020 | $143,000 | – | 57,566 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| XTX Topco Ltd | 29,269 | $63,000 | 0.02% |
| SeaCrest Wealth Management, LLC | 43,563 | $94,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 246,000 | $529,000 | 0.01% |
| Lehman & Derafelo Financial Resources LLC | 11,100 | $24,000 | 0.01% |
| WINTON GROUP Ltd | 54,894 | $118,000 | 0.01% |
| Traynor Capital Management, Inc. | 11,777 | $24,000 | 0.00% |
| Community Bank, N.A. | 13,226 | $28,000 | 0.00% |
| SNS Financial Group, LLC | 10,000 | $22,000 | 0.00% |
| Verition Fund Management LLC | 108,000 | $232,000 | 0.00% |
| Schonfeld Strategic Advisors LLC | 23,100 | $49,000 | 0.00% |